Princess Margaret Cancer Centre - University Health Network — Toronto, Ontario

Public research footprint of Princess Margaret Cancer Centre - University Health Network, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Advanced Non-small Cell Lung Cancer, HER2 Mutation · Multiple Myeloma · Carcinoma, Non-Small-Cell Lung · Lymphoma, Large B-Cell, Diffuse

Recently updated registry entries

NCT06635824 — Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of… (Active Not Recruiting)
NCT07185997 — Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's… (Recruiting)
NCT04811560 — A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Princess Margaret Cancer Centre - University Health Network?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.